Skip to main content

Month: May 2020

Plug Power Inc. Announces Private Offering of $200 Million of Convertible Senior Notes

LATHAM, N.Y. , May 13, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (“Plug Power”) (NASDAQ: PLUG) today announced its intention to offer, subject to market conditions and other factors, $200 million aggregate principal amount of Convertible Senior Notes due 2025 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Plug Power also expects to grant the initial purchasers of the notes a 13-day option to purchase up to an additional $30 million aggregate principal amount of the notes.The notes will be senior, unsecured obligations of Plug Power, and interest will be payable semi-annually in arrears. The notes will be convertible into cash, shares of Plug Power’s common stock or a combination thereof, at Plug Power’s...

Continue reading

Argonaut Gold and Alio Gold Merger: Reminder to Vote

TORONTO and VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — Argonaut Gold Inc. (“Argonaut” or “Argonaut Gold”) (TSX: AR) and Alio Gold Inc. (“Alio” or “Alio Gold”) (TSX, NYSE-A: ALO) would like to remind shareholders and certain securityholders (in the case of Alio) that they have until 11:30 a.m. (Eastern time) or 8:30 a.m. (Pacific time) on Friday May 15, 2020 to vote their shares or securities by proxy at the companies’ respective upcoming Annual and Special Meetings.Each of the Argonaut Gold and Alio Gold Board of Directors has unanimously recommended that the shareholders and certain securityholders (in the case of Alio) of their respective companies vote FOR each of the proposed resolutions to be considered at their respective Annual and Special Meetings.  In addition, both Institutional Shareholder Services and...

Continue reading

Invitation to IDEX Biometrics’ conference call for the first quarter of 2020

IDEX Biometrics ASA will publish its result for the first quarter of 2020 on Thursday 14 May 2020, and CEO Vince Graziani and CFO Derek D’Antilio will hold a conference call at 15:00 CET.Dial in numbers:Norway:                       +47 2350 0243Sweden:                      +46 8566 42651United Kingdom:         +44 3333 000804United States:             +1 631 913 1422Confirmation code:     16628677For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.com   Tel: + 47 918 00186Derek D’Antilio, Chief financial OfficerE-mail: derek.dantilio@idexbiometrics.com   Tel: +1 197 827 31344About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all.  We help people make...

Continue reading

SeaBird Exploration Plc: first quarter 2020 presentation and webcast

13 May 2020, Limassol, CyprusSeaBird Exploration will present their financial results for the first quarter of 2020 on Friday, 15 May. There will be an investor presentation at 08:00 hours at SeaBird’s offices in Sandviksbodene 68, Bergen. The presentation will be transmitted live and a recorded version will be available shortly thereafter. Please use the following conference call link:https://teams.microsoft.com/l/meetup-join/19%3ameeting_MzA4MmYzNTktN2UwZi00ZmU0LWI5ZWEtOGRjZmUwNDI1ZDdk%40thread.v2/0?context=%7b%22Tid%22%3a%22d7181576-1d07-4383-b8ac-6451ab33feae%22%2c%22Oid%22%3a%229f628170-3a21-4974-8f7d-3307a5fc7db6%22%2c%22IsBroadcastMeeting%22%3atrue%7dSeaBird is a global provider of marine acquisition for 2D/3D and 4D seismic data, and associated products and services to the oil and gas industry. SeaBird specializes in high...

Continue reading

ProMIS Neurosciences Announces First Quarter 2020 Results

TORONTO and CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS or the Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced its operational and financial results for the three months ended March 31, 2020.“Over the course of the first quarter 2020, the value of our unique discovery and development platform was further evidenced as ProMIS made considerable progress in expanding its portfolio of opportunities across multiple neurodegenerative diseases,” stated Eugene Williams, ProMIS’ Executive Chairman.“PMN310, our lead antibody therapeutic candidate for Alzheimer’s disease (AD), showed further significant positive differentiation...

Continue reading

Veru Reports Strong Fiscal 2020 Second Quarter Results as Net Revenues Increase 43%, Gross Profit Up 61%

–Strong Clinical Progress in Advanced Prostate Cancer: VERU-111 Demonstrates Safety and Evidence of Antitumor Activity with Durable PSA Declines and Tumor Regression in Phase 1b Study; Phase 2 Study Enrolling; Plan to Meet with FDA as Positive Clinical Data Supports Clinical Advancement to Pivotal Phase 3 Study––Unique Dual Mechanism of Action of VERU-111 Potentially Effective Against COVID-19;FDA Grants Permission to Initiate Phase 2 Clinical Study; First Patient to be Dosed within 2 Weeks– –Commercial Business Continues to Deliver Robust Growth––Company to Host Investor Conference Call Today at 8 a.m. ETto Discuss Financial Results and Business Highlights–MIAMI, May 13, 2020 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with a focus...

Continue reading

Endeavour Reports Record Operating Cash Flow in Q1-2020

ENDEAVOUR REPORTS RECORDOPERATING CASH FLOW IN Q1-2020Net Debt down $55m in Q1-2020 · Well positioned to meet FY-2020 production and AISC guidance HighlightsStrong Q1-2020 performance with production of 172koz at an AISC of $899/oz; well positioned to meetFY- 2020 guidanceQ1-2020 production increased by 42% over Q1-2019, driven by the start-up of the Ity CIL operation, while AISC increased by 3% to $899/ozRecord Operating Cash Flow of $126m in Q1-2020, a fivefold increase over Q1-2019Net debt was reduced by $55m in Q1-2020 to $473m, marking a reduction of $187m over the past three quarters, following nearly four years of intensive growth-capital investmentHealthy Net Debt / Adjusted EBITDA (LTM) of 1.06x at quarter-end, a reduction of 64% from 2.96x at the end of Q1-2019Cash reserves of $357m at quarter-end, providing significant headroom...

Continue reading

Oma Säästöpankki Oyj: Johdon liiketoimet – Ville Rissanen

OMA SÄÄSTÖPANKKI OYJ, PÖRSSITIEDOTE 13.5.2020 KLO 13.30, JOHTOHENKILÖIDEN LIIKETOIMETOma Säästöpankki Oyj: Johdon liiketoimet – Ville RissanenIlmoitusvelvollinen:Nimi: Rissanen VilleAsema: Muu ylin johtoLiikkeeseenlaskija: Oma Säästöpankki OyjLEI: 743700LE1ECAPXC5UT18Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700LE1ECAPXC5UT18_20200512215458_2Liiketoimen päivämäärä: 12.5.2020Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Liiketoimen luonne: HANKINTAInstrumenttityyppi: OSAKEISIN: FI4000306733Liiketoimien yksityiskohtaiset tiedot(1) Volyymi: 54 Yksikköhinta: 7,50 EUR(2) Volyymi: 71 Yksikköhinta: 7,42 EUR(3) Volyymi: 320 Yksikköhinta: 7,40 EUR(4) Volyymi: 255 Yksikköhinta: 7,32 EURLiiketoimien yhdistetyt tiedot(4) Volyymi: 700 Keskihinta: 7,38060 EUROma Säästöpankki OyjLisätiedot:Minna Sillanpää, viestintäjohtaja, puh +358 50...

Continue reading

Oma Savings Bank Plc: Manager’s Transactions – Ville Rissanen

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 13 MAY 2020 13.30 P.M. EET, MANAGER’S TRANSACTIONSOma Savings Bank Plc: Manager´s Transactions – Ville RissanenPerson subject to the notification requirements:Name: Rissanen VillePosition: Other senior managerIssuer: Oma Savings Bank PlcLEI: 743700LE1ECAPXC5UT18Notification type: INITIAL NOTIFICATIONReference number: 743700LE1ECAPXC5UT18_20200512215458_2Transaction date: 2020-05-12Venue: NASDAQ HELSINKI LTD (XHEL)Nature of the transaction: ACQUISITIONInstrument type: SHAREISIN: FI4000306733Transaction details(1) Volume: 54 Unit price: 7.50 EUR(2) Volume: 71 Unit price: 7.42 EUR(3) Volume: 320 Unit price: 7.40 EUR(4) Volume: 255 Unit price: 7.32 EURAggregated transactions(4) Volume: 700 Volume weighted average price: 7.38060 EUROma Savings Bank PlcFurther enquiries:Minna Sillanpää, Chief...

Continue reading

Endeavour Silver Announces 2020 Annual General Meeting Results

VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (TSX: EDR; NYSE: EXK) announces that at the Company’s 2020 Annual General Meeting (“AGM”) held on May 12, 2020 in Vancouver, shareholders voted in favour of all items of business. A total of 67,042,666 votes were cast or represented by proxy at the AGM, representing 47.28% of the outstanding common shares as of the record date. The following is a tabulation of the votes submitted by proxy:All director nominees were re‑elected.By a vote by show of hands, shareholders voted 87.18% in favour of re‑appointing KPMG LLP as auditor of the Company and authorized the Board to fix the auditor’s remuneration for the ensuing year.About Endeavour ‑ Endeavour Silver Corp. is a mid-tier precious metals mining company that owns and operates three high-grade,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.